Elisabeth Pimpisa Graarud
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Elisabeth Pimpisa Graarud has a total of 31 co-authors. Here are the top co-authors by number of shared publications:
- Chun-Mei Zhao
Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway
2 shared publications Anil K Rustgi
Divison of Digestive and Liver Diseases, Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York, USA
1 shared publication- Anil K. Rustgi
Columbia University Irving Medical Center 3 Division of Digestive and Liver Diseases, Department of Medicine, Vagelos College of Physicians and Surgeons New York, New York
1 shared publication Animesh Sharma
PROMEC - Proteomics and Modomics Experimental Core Facility at NTNU and the Central Norway Regional Health Authority, Trondheim, Norway
1 shared publication- Animesh Sharma
Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway
1 shared publication Anne Aarvik
Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway
1 shared publication
Latest Publications
- Open Access
Knowledge Discovery in Databases of Proteomics by Systems Modeling in Translational Research on Pancreatic Cancer
Background: Knowledge discovery in databases (KDD) can contribute to translational research, also known as translational medicine, by bridging the gap between in vitro and in vivo studies, and clinical applications. Here, we propose a ‘systems modeling’ workflow for KDD. Methods: This framework includes the data collection of a composition model (various research models), processing model (proteomics) and analytical model (bioinformatics, artificial intelligence/machine leaning and pattern evaluation), knowledge presentation, and feedback loops for hypothesis generation and validation. We applied this workflow to study pancreatic ductal adenocarcinoma (PDAC). Results: We identified the common proteins between human PDAC and various research models in vitro (cells, spheroids and organoids) and in vivo (mouse mice). Accordingly, we hypothesized potential translational targets on hub proteins and the related signaling pathways, PDAC-specific proteins and signature pathways, and high topological proteins. Conclusions: This systems modeling workflow can be a valuable method for KDD, facilitating knowledge discovery in translational targets in general, and in particular to PADA in this case.
Open AccessKnowledge Discovery in Databases of Proteomics by Systems Modeling in Translational Research on Pancreatic Cancer
Background: Knowledge discovery in databases (KDD) can contribute to translational research, also known as translational medicine, by bridging the gap between in vitro and in vivo studies, and clinical applications. Here, we propose a ‘systems modeling’ workflow for KDD. Methods: This framework includes the data collection of a composition model (various research models), processing model (proteomics) and analytical model (bioinformatics, artificial intelligence/machine leaning and pattern evaluation), knowledge presentation, and feedback loops for hypothesis generation and validation. We applied this workflow to study pancreatic ductal adenocarcinoma (PDAC). Results: We identified the common proteins between human PDAC and various research models in vitro (cells, spheroids and organoids) and in vivo (mouse mice). Accordingly, we hypothesized potential translational targets on hub proteins and the related signaling pathways, PDAC-specific proteins and signature pathways, and high topological proteins. Conclusions: This systems modeling workflow can be a valuable method for KDD, facilitating knowledge discovery in translational targets in general, and in particular to PADA in this case.
- Open Access
Knowledge Discovery in Datasets of Proteomics by Systems Modeling in Translational Research on Pancreatic Cancer
Knowledge discovery in databases (KDD) can contribute to translational research, also known as translational medicine, by bridging the gap between in vitro and in vivo studies and clinical applications. Here, we propose a ‘systems modeling’ workflow for KDD. This framework includes data collection of composition model (various research models) and processing model (proteomics) and analytical model (bioinformatics, artificial intelligence/machine leaning and pattern evaluation), knowledge presentation, and feedback loops for hypothesis generation and validation. We applied this workflow to study pancreatic ductal adenocarcinoma (PDAC). Through this approach, we identified the common proteins between human PDAC and various research models in vitro (cells, spheroids and organoids) and in vivo (mouse mice). Accordingly, we hypothesized potential translational targets on hub proteins and the related signaling pathways, PDAC specific proteins and signature pathways, and high topological proteins. Thus, we suggest that this systems modeling workflow can be a valuable method for KDD, facilitating knowledge discovery in translational targets in general and in particular to PADA in this case.
Open AccessKnowledge Discovery in Datasets of Proteomics by Systems Modeling in Translational Research on Pancreatic Cancer
Knowledge discovery in databases (KDD) can contribute to translational research, also known as translational medicine, by bridging the gap between in vitro and in vivo studies and clinical applications. Here, we propose a ‘systems modeling’ workflow for KDD. This framework includes data collection of composition model (various research models) and processing model (proteomics) and analytical model (bioinformatics, artificial intelligence/machine leaning and pattern evaluation), knowledge presentation, and feedback loops for hypothesis generation and validation. We applied this workflow to study pancreatic ductal adenocarcinoma (PDAC). Through this approach, we identified the common proteins between human PDAC and various research models in vitro (cells, spheroids and organoids) and in vivo (mouse mice). Accordingly, we hypothesized potential translational targets on hub proteins and the related signaling pathways, PDAC specific proteins and signature pathways, and high topological proteins. Thus, we suggest that this systems modeling workflow can be a valuable method for KDD, facilitating knowledge discovery in translational targets in general and in particular to PADA in this case.